SHULMAN JOHN D 13D and 13G filings for Petros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-28 4:30 pm Purchase | 2021-12-02 | 13D | Petros Pharmaceuticals, Inc. PTPI | SHULMAN JOHN D | 31,524 34.470% | 4,545 (+16.85%) | Filing |
| 2021-10-20 5:25 pm Purchase | 2021-10-18 | 13D | Petros Pharmaceuticals, Inc. PTPI | SHULMAN JOHN D | 26,978 51.190% | 13,394 (+98.61%) | Filing |
| 2020-12-11 5:26 pm Purchase | 2020-12-01 | 13D | Petros Pharmaceuticals, Inc. PTPI | SHULMAN JOHN D | 13,584 34.900% | 13,584 (New Position) | Filing |